BREVEGLIERI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 8.220
AS - Asia 4.722
EU - Europa 3.682
SA - Sud America 823
AF - Africa 88
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 17.560
Nazione #
US - Stati Uniti d'America 8.047
SG - Singapore 1.770
CN - Cina 1.658
PL - Polonia 856
IT - Italia 805
BR - Brasile 711
DE - Germania 498
UA - Ucraina 436
HK - Hong Kong 419
GB - Regno Unito 290
TR - Turchia 250
VN - Vietnam 236
SE - Svezia 193
FI - Finlandia 158
RU - Federazione Russa 128
FR - Francia 108
ID - Indonesia 89
CA - Canada 84
IN - India 67
MX - Messico 67
NL - Olanda 56
AR - Argentina 48
JP - Giappone 40
ZA - Sudafrica 37
IR - Iran 35
BD - Bangladesh 33
BE - Belgio 33
ES - Italia 33
EC - Ecuador 21
CZ - Repubblica Ceca 18
KR - Corea 18
PK - Pakistan 18
LT - Lituania 17
AU - Australia 16
IQ - Iraq 14
CO - Colombia 13
TN - Tunisia 11
EG - Egitto 9
PY - Paraguay 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
AT - Austria 8
KE - Kenya 8
MY - Malesia 8
UZ - Uzbekistan 8
TW - Taiwan 7
VE - Venezuela 7
AZ - Azerbaigian 6
BG - Bulgaria 6
MA - Marocco 6
PE - Perù 6
CH - Svizzera 5
DZ - Algeria 5
NZ - Nuova Zelanda 5
PA - Panama 5
CL - Cile 4
ET - Etiopia 4
JO - Giordania 4
PT - Portogallo 4
GR - Grecia 3
SA - Arabia Saudita 3
TH - Thailandia 3
UY - Uruguay 3
YE - Yemen 3
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GE - Georgia 2
HN - Honduras 2
IE - Irlanda 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DM - Dominica 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
Totale 17.541
Città #
Singapore 997
Warsaw 844
Ashburn 839
Woodbridge 698
Beijing 670
Fairfield 558
Chandler 557
Houston 494
Ann Arbor 492
Jacksonville 485
Hong Kong 412
Santa Clara 402
Ferrara 280
Wilmington 274
Seattle 239
Dallas 201
Nanjing 183
Cambridge 166
New York 146
Izmir 145
Los Angeles 125
Princeton 116
Bologna 115
Munich 109
Boardman 89
Addison 84
Ho Chi Minh City 84
Milan 75
Shanghai 75
Jakarta 64
Shenyang 58
Bremen 55
Hanoi 55
San Diego 51
Redwood City 48
São Paulo 48
Nanchang 46
Mexico City 42
Turku 42
Brooklyn 41
Falls Church 36
London 36
Hebei 35
Hefei 33
Moscow 32
Dearborn 31
Denver 31
Tokyo 31
Stockholm 30
Brussels 29
Hangzhou 29
Changsha 28
Rio de Janeiro 28
San Jose 28
Guangzhou 27
Toronto 27
Zhengzhou 27
Tianjin 25
Auburn Hills 24
Johannesburg 24
Orem 24
Jiaxing 23
Montreal 23
San Francisco 22
Mountain View 21
Poplar 21
Buffalo 20
Verona 20
Chennai 19
Dong Ket 19
Manchester 19
Brasília 18
The Dalles 18
Curitiba 17
Phoenix 17
Chicago 16
Frankfurt am Main 16
Norwalk 16
Atlanta 15
Helsinki 15
Jinan 15
Ningbo 15
Nuremberg 15
Orange 14
Belo Horizonte 13
Boston 13
Brno 13
Columbus 13
Council Bluffs 13
Ferrara di Monte Baldo 13
Kunming 13
Falkenstein 12
Guayaquil 12
Ankara 11
Rome 11
Amsterdam 10
Haiphong 10
Indiana 10
Napoli 10
Sydney 10
Totale 11.720
Nome #
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 384
A validated cellular biobank for β-thalassemia 364
Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays 336
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 315
A validated THALAMOSS cellular biobank for β-thalassemia 291
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 270
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 247
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 246
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 241
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 229
SPR-based non-invasive prenatal testing for fetal sex determination 216
Surface plasmon resonance analysis to detect the β+ IVSI-110 thalassemia mutation in circulating cell-free fetal DNA 212
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 207
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 199
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 194
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 190
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 189
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 188
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 187
C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells 186
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 184
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 183
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 182
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 177
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 172
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 170
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 166
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 163
Effect of bioencapsulation on the secretomic profile o fIB3-1 cystic fibrosis cells 163
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 163
Non-invasive fetal sex diagnosis in plasma of early weeks pregnants using droplet digital PCR 161
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 160
Detection of the sickle hemoglobin allele using a surface plasmon resonance based biosensor 160
Antisense PNA and PNA-peptide conjugates for the modulation of the beta-globin gene splicing 159
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 156
Biological evaluation of psoralen derivatives as inhibitors of NF-κB/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression 156
Alteration of microRNA biological activity with peptide nucleic acid 155
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 155
Droplet Digital PCR for Non-Invasive Prenatal Detection of Fetal Single-Gene Point Mutations in Maternal Plasma 155
Modulation of the Biological Activity of microRNA-210 with Peptide Nucleic Acids (PNAs) 153
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 151
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 150
Cellular biosensors for the identification of fetal hemoglobin inducers 145
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 145
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 144
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 144
Real-time multiplex analysis of four beta-thalassemia mutations employing surface plasmon resonance and biosensor technology 141
Development and molecular characterization of transgenic mice for beta-thalassemia 140
Detection methods for the identification of Alicyclobacillus species involved in food spoilage 137
Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221. 136
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 134
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 132
Gene therapy combined with HbF induction in beta-thalassemia 131
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients 130
Non-invasive Prenatal Testing Using Fetal DNA 130
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 127
Transcription factors (TFs) negatively regulating gamma-globin gene transcription: BCL11A is down-regulated during mithramycin induction of erythroid cells from beta-thalassemia patients 127
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 126
TNF-alpha induced release of IL-8 by IB3-1 cells encapsulated in alginate microbeads 123
Targeting the miR-221/miR-222 cluster in cancer therapy 123
Peptide nucleic acids targeting miR-221 in human breast cancer: uptake and modulation of miR-221 biological functions. 120
Detection of genomic disorders in unamplified human genomic DNA using an ultrasensitive surface plasmon resonance imaging method 119
Non-invasive prenatal detection of beta-thalassemia mutations in maternal plasma using Droplet Digital PCR 119
MTOR and STAT3 pathway hyper-activation is associated with elevated interleukin-6 levels in patients with shwachman-diamond syndrome: Further evidence of lymphoid lineage impairment 118
Gene therapy and fetal hemoglobin induction 117
null 117
Surface plasmon resonance and biosensor technology for real-time molecular diagnosis of β°39 thalassemia mutation 115
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 115
In vitro induction of interleukin-8 by SARS-CoV-2 Spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR 115
Sirolimus-mediated induction of fetal hemoglobin in beta-thalassemia: impact of the XmnI rs74482144 polymophism 115
Up-regulation of miR-34a-3p and miR-744-3p is associated with down-regulation of PTEN in lymphoblastoid cells from Shwachman-Diamond Syndrome patients 114
IL-17 family members exert an autocrine pro-inflammatory loop in CF respiratory epithelial cells ex vivo 113
Constitutive systemic inflammation in Shwachman-Diamond Syndrome 113
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 109
Detection of disorders in unamplified human genomic DNA 109
Inhibition of micro RNA 210 biological activity with an anti-miR-210 peptide nucleic acid 108
Produzione di emoglobina in cellule Eritroidi da pazienti con Beta Talassemia alterando processi biomolecolari in grado di regolare l'espressione dei geni per le globine. 108
P1 promoter transcriptional activity of the human AbetaH-J-J locus, encoding Aspartil-beta-hydroxylase, Junctin and Junctate 107
null 107
Hemoglobin production in beta-thalassemia erythroid cells following alteration of biomolecular pathways regulating globin gene expression 106
Multiple levels of control of the expression of the human AβH-J-J locus encoding aspartyl-β-hydroxylase, junctin, and junctate 105
Surface Plasmon Resonance Imaging (SPR-I), peptide nucleic acid (PNA) probes and nanoparticle-enhancement for PCR-free ultrasensitive detection of beta-thalassemia mutations in human genomic DNA 105
A Signature of Differentially Expressed Micrornas in Lymphoblastoid Cells from Shwachman-Diamond Syndrome Patients Indicates Possible Molecular Targets for Mirna Therapeutics 105
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 104
Peptide nucleic acids targeting miR-221 in breast cancer cell lines: uptake and modulation of miR-221 and p27kip1 biological function 104
SPR-based identification of microRNAs 104
Evidences for miRNA regulation of BCL11A gene expression 104
Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs 104
PNA-mediated alteration of mRNA splicing 103
null 103
Therapeutic molecules for the development of a read-through approach for diseases caused by nonsense mutations 102
null 102
Readthrough of the premature stop codon beta039-thalassemia 97
Thalassemia mouse model for beta-globin gene IVSI-6 mutation 97
null 96
Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus 95
null 94
Molecular regulation of the expression of AbetaHJ-J locus, encoding Aspartyl-beta-hydroxylase, Junctin and Junctate 94
Inhibition of micro RNA 221 biological activity with an anti-miR-221 peptide nucleic acid 94
Polyarginine peptide nucleic acids inhibit biological activity if microRNA 210 94
Totale 15.170
Categoria #
all - tutte 80.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.494
Totale 81.520


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.223 0 0 0 0 0 204 118 156 66 223 302 154
2021/20221.223 139 103 33 40 85 70 60 48 51 110 104 380
2022/20231.278 137 124 25 161 224 167 74 116 130 10 52 58
2023/2024808 50 107 35 31 64 156 82 42 11 16 52 162
2024/20252.965 80 70 230 154 305 246 127 144 511 327 391 380
2025/20264.384 818 318 670 1.012 1.252 314 0 0 0 0 0 0
Totale 17.845